Personensuche
X
?
1
Additional file 3 of Long-term outcomes of 0.1% tacrolimus ..:
Hiroyuki Yazu (10066796) ; Kazumi Fukagawa (617495) ; Eisuke Shimizu (705531)..
https://figshare.com/articles/journal_contribution/Additional_file_3_of_Long-term_outcomes_of_0_1_tacrolimus_eye_drops_in_eyes_with_severe_allergic_conjunctival_diseases/13684550. , 2021
https://figshare.com/articles/journal_contribution/Additional_file_3_of_Long-term_outcomes_of_0_1_tacrolimus_eye_drops_in_eyes_with_severe_allergic_conjunctival_diseases/13684550. , 2021
?
2
Additional file 1 of Long-term outcomes of 0.1% tacrolimus ..:
Hiroyuki Yazu (10066796) ; Kazumi Fukagawa (617495) ; Eisuke Shimizu (705531)..
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Long-term_outcomes_of_0_1_tacrolimus_eye_drops_in_eyes_with_severe_allergic_conjunctival_diseases/13684544. , 2021
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Long-term_outcomes_of_0_1_tacrolimus_eye_drops_in_eyes_with_severe_allergic_conjunctival_diseases/13684544. , 2021
?
3
Additional file 2 of Long-term outcomes of 0.1% tacrolimus ..:
Hiroyuki Yazu (10066796) ; Kazumi Fukagawa (617495) ; Eisuke Shimizu (705531)..
https://figshare.com/articles/journal_contribution/Additional_file_2_of_Long-term_outcomes_of_0_1_tacrolimus_eye_drops_in_eyes_with_severe_allergic_conjunctival_diseases/13684547. , 2021
https://figshare.com/articles/journal_contribution/Additional_file_2_of_Long-term_outcomes_of_0_1_tacrolimus_eye_drops_in_eyes_with_severe_allergic_conjunctival_diseases/13684547. , 2021
1-3